ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IDP Biogen Inc

202.70
-0.90 (-0.44%)
00:44:09 - Realtime Data
Share Name Share Symbol Market Stock Type
Biogen Inc IDP Tradegate Ordinary Share
  Price Change Price Change % Share Price Last Trade
-0.90 -0.44% 202.70 00:44:09
Open Price Low Price High Price Close Price Previous Close
204.60 201.70 204.60 203.60
more quote information »

Recent News

Date Time Source Heading
26/4/202406:05GLOBEBiogen Receives Positive CHMP Opinion for TOFIDENCE™..
06/3/202423:30GLOBENew Biomarker Data Add Further Evidence Supporting the..
05/3/202408:15GLOBEBiogen Highlights New Data at the International Conference..
23/2/202423:00GLOBEBiogen’s QALSODY® (tofersen), the First Therapy to Treat..
13/2/202408:06GLOBEBiogen Received European Commission Approval for SKYCLARYS®..
31/1/202423:30GLOBEBiogen to Realign Resources for Alzheimer's Disease..
19/12/202323:30GLOBECentralized Marketing Authorizations of Generic Versions of..
16/12/202301:05GLOBECHMP Issues Positive Opinion for Biogen’s SKYCLARYS®..
14/12/202322:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
06/11/202323:30GLOBEBiogen Appoints Monish Patolawala to its Board of Directors
26/10/202308:26GLOBEEisai Presents New LEQEMBI® (lecanemab-irmb) Investigational..
19/10/202322:30GLOBEBiogen to Present New Data at the Clinical Trials on..
26/9/202322:59GLOBEBiogen Completes Acquisition of Reata Pharmaceuticals
25/9/202315:02GLOBELEQEMBI® Intravenous Infusion (Lecanemab) Approved for the..
06/9/202321:30GLOBEBiogen Appoints Jane Grogan as Head of Research
05/8/202312:41GLOBEFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
28/7/202321:05GLOBEBiogen to Acquire Reata Pharmaceuticals
20/7/202309:30GLOBEEisai Presents Latest Analysis of Lecanemab’s Effect on..
07/7/202310:00GLOBEFDA Grants Traditional Approval for LEQEMBI®..
13/6/202307:14GLOBEBiogen Announces Changes to Its Board of Directors
10/6/202308:45GLOBEFDA Advisory Committee Votes Unanimously to Confirm the..
16/5/202309:30GLOBEHealth Canada Accepts New Drug Submission for Lecanemab as..

Your Recent History

Delayed Upgrade Clock